97 related articles for article (PubMed ID: 20154279)
1. PAX5 expression in nonhematopoietic tissues. Reappraisal of previous studies.
Morgenstern DA; Hasan F; Gibson S; Winyard P; Sebire NJ; Anderson J
Am J Clin Pathol; 2010 Mar; 133(3):407-15. PubMed ID: 20154279
[TBL] [Abstract][Full Text] [Related]
2. PAX immunoreactivity identifies alveolar rhabdomyosarcoma.
Sullivan LM; Atkins KA; LeGallo RD
Am J Surg Pathol; 2009 May; 33(5):775-80. PubMed ID: 19145202
[TBL] [Abstract][Full Text] [Related]
3. Multiple isoforms of PAX5 are expressed in both lymphomas and normal B-cells.
Arseneau JR; Laflamme M; Lewis SM; Maïcas E; Ouellette RJ
Br J Haematol; 2009 Nov; 147(3):328-38. PubMed ID: 19725825
[TBL] [Abstract][Full Text] [Related]
4. PAX immunoreactivity in poorly differentiated small round cell tumors of childhood.
Fan R
Fetal Pediatr Pathol; 2014 Aug; 33(4):244-52. PubMed ID: 24897005
[TBL] [Abstract][Full Text] [Related]
5. Characterization of a new monoclonal antibody against PAX5/BASP in 1525 paraffin-embedded human and animal tissue samples.
Agostinelli C; Sabattini E; Gjørret JO; Righi S; Rossi M; Mancini M; Piccaluga PP; Bacci F; Marafioti T; Bettini G; Falini B; Pileri SA
Appl Immunohistochem Mol Morphol; 2010 Dec; 18(6):561-72. PubMed ID: 20697266
[TBL] [Abstract][Full Text] [Related]
6. Activating PAX gene family paralogs to complement PAX5 leukemia driver mutations.
Hart MR; Anderson DJ; Porter CC; Neff T; Levin M; Horwitz MS
PLoS Genet; 2018 Sep; 14(9):e1007642. PubMed ID: 30216339
[TBL] [Abstract][Full Text] [Related]
7. Expression profiling of transcription factors in B- or T-acute lymphoblastic leukemia/lymphoma and burkitt lymphoma: usefulness of PAX5 immunostaining as pan-Pre-B-cell marker.
Nasr MR; Rosenthal N; Syrbu S
Am J Clin Pathol; 2010 Jan; 133(1):41-8. PubMed ID: 20023257
[TBL] [Abstract][Full Text] [Related]
8. Overexpression of PAX5 in oral carcinogenesis.
Norhany S; Kouzu Y; Uzawa K; Hayama M; Higo M; Koike H; Kasamatu A; Tanzawa H
Oncol Rep; 2006 Nov; 16(5):1003-8. PubMed ID: 17016584
[TBL] [Abstract][Full Text] [Related]
9. The expression of WT1 in the differentiation of rhabdomyosarcoma from other pediatric small round blue cell tumors.
Carpentieri DF; Nichols K; Chou PM; Matthews M; Pawel B; Huff D
Mod Pathol; 2002 Oct; 15(10):1080-6. PubMed ID: 12379755
[TBL] [Abstract][Full Text] [Related]
10. N-terminal PAX8 polyclonal antibody shows cross-reactivity with N-terminal region of PAX5 and is responsible for reports of PAX8 positivity in malignant lymphomas.
Moretti L; Medeiros LJ; Kunkalla K; Williams MD; Singh RR; Vega F
Mod Pathol; 2012 Feb; 25(2):231-6. PubMed ID: 22037256
[TBL] [Abstract][Full Text] [Related]
11. [PAX gene function during kidney tumorigenesis: a comparative approach].
Béland M; Bouchard M
Bull Cancer; 2006 Sep; 93(9):875-82. PubMed ID: 16980230
[TBL] [Abstract][Full Text] [Related]
12. Expression of mRNA for a newly identified Pax5 exon is reduced in multiple myeloma.
Borson ND; Lacy MQ; Wettstein PJ
Mamm Genome; 2006 Mar; 17(3):248-56. PubMed ID: 16518692
[TBL] [Abstract][Full Text] [Related]
13. Isoforms of Pax5 and co-regulation of T- and B-cells associated genes influence phenotypic traits of ascetic cells causing Dalton's lymphoma.
Bharti B; Mishra R
Biochim Biophys Acta; 2011 Dec; 1813(12):2071-8. PubMed ID: 21854813
[TBL] [Abstract][Full Text] [Related]
14. PAX5 expression in acute leukemias: higher B-lineage specificity than CD79a and selective association with t(8;21)-acute myelogenous leukemia.
Tiacci E; Pileri S; Orleth A; Pacini R; Tabarrini A; Frenguelli F; Liso A; Diverio D; Lo-Coco F; Falini B
Cancer Res; 2004 Oct; 64(20):7399-404. PubMed ID: 15492262
[TBL] [Abstract][Full Text] [Related]
15. Expression of the B cell-associated transcription factors PAX5, OCT-2, and BOB.1 in acute myeloid leukemia: associations with B-cell antigen expression and myelomonocytic maturation.
Gibson SE; Dong HY; Advani AS; Hsi ED
Am J Clin Pathol; 2006 Dec; 126(6):916-24. PubMed ID: 17074681
[TBL] [Abstract][Full Text] [Related]
16. Expression and production of aberrant PAX5 with deletion of exon 8 in B-lineage acute lymphoblastic leukaemia of children.
Sadakane Y; Zaitsu M; Nishi M; Sugita K; Mizutani S; Matsuzaki A; Sueoka E; Hamasaki Y; Ishii E
Br J Haematol; 2007 Jan; 136(2):297-300. PubMed ID: 17129225
[TBL] [Abstract][Full Text] [Related]
17. Paired box 5 is a novel marker of breast cancers that is frequently downregulated by methylation.
Li X; Huang J; Luo X; Yang D; Yin X; Peng W; Bi C; Ren G; Xiang T
Int J Biol Sci; 2018; 14(12):1686-1695. PubMed ID: 30416383
[TBL] [Abstract][Full Text] [Related]
18. Diagnostic utility of nestin expression in pediatric tumors in the region of the kidney.
Murphy AJ; Viero S; Ho M; Thorner PS
Appl Immunohistochem Mol Morphol; 2009 Dec; 17(6):517-23. PubMed ID: 19417621
[TBL] [Abstract][Full Text] [Related]
19. Diagnostic uses of Pax5 immunohistochemistry.
Feldman AL; Dogan A
Adv Anat Pathol; 2007 Sep; 14(5):323-34. PubMed ID: 17717432
[TBL] [Abstract][Full Text] [Related]
20. Immunohistochemistry of primary malignant neuroepithelial tumors of the kidney: a potential source of confusion? A study of 30 cases from the National Wilms Tumor Study Pathology Center.
Ellison DA; Parham DM; Bridge J; Beckwith JB
Hum Pathol; 2007 Feb; 38(2):205-11. PubMed ID: 17134738
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
